Assembly Biosciences
ASMB
103 hedge funds and large institutions have $435M invested in Assembly Biosciences in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 30 reducing their positions, and 14 closing their positions.
374% more call options, than puts
Call options by funds: $3.95M | Put options by funds: $833K
33% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 30
0.22% more ownership
Funds ownership: 6.99% → 7.21% (+0.22%)
3% less funds holding
Funds holding: 106 → 103 (-3)
10% less capital invested
Capital invested by funds: $483M → $435M (-$47.5M)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$21.7M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$11.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$8.03M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.1M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$26.4M |
| 2 |
RI
RTW Investments
New York
|
-$15.5M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$5.27M |
| 4 |
BlackRock
New York
|
-$3.58M |
| 5 |
3C
361 Capital
Denver,
Colorado
|
-$2.59M |
ASMB Hedge Fund Activity: Q1 2019 in Review
103 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2019, worth a combined $435M — down 9.8% from $483M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ASMB and 11 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 40 added.
The largest buyer was Armistice Capital, adding an estimated $21.7M. The largest seller was EcoR1 Capital, cutting an estimated $26.4M.
- 103 institutional investors held Assembly Biosciences (ASMB) as of Q1 2019, down from 106 in Q4 2018.
- Funds reported $435M of Assembly Biosciences stock for Q1 2019, down 9.8% quarter-over-quarter.
- 11 funds opened new Assembly Biosciences positions in Q1 2019 and 14 closed out, a net change of -3 holders.
- The largest Assembly Biosciences buyer in Q1 2019 was Armistice Capital, an estimated $21.7M added.
- The largest Assembly Biosciences seller in Q1 2019 was EcoR1 Capital, an estimated $26.4M sold.
Based on aggregated 13F filings for Q1 2019.